Two factors predict survival in AML

Time to relapse after an allogeneic stem cell transplant and the extent of graft versus host disease (GVHD) are the two key factors predicting outcome in patients with relapsed acute myeloid leukaemia (AML). A retrospective study of 386 patients from around Australia found relapse within six months of transplant and grade 3-4 acute GVHD preceding relapse were ...

Already a member?

Login to keep reading.

© 2021 the limbic